Jim Simons Alterity Therapeutics LTD Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$0.02 - $0.03 $4,758 - $7,137
-237,903 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$0.02 - $0.03 $264 - $396
13,213 Added 5.88%
237,903 $309,000
Q1 2021

May 13, 2021
SELL
$0.02 - $0.03 $1,936 - $2,904
-96,810 Reduced 30.11%
224,690 $324,000
Q4 2020

Feb 10, 2021
BUY
$0.01 - $0.05 $1,592 - $7,964
159,281 Added 98.19%
321,500 $431,000
Q3 2020

Nov 13, 2020
BUY
$0.0 - $0.05 $0 - $8,110
162,219 New
162,219 $328,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ALTERITY THERAPEUTICS LTD

ATHE Quotes by TradingView
  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $52.6M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email